KES has worked with Microbaric Oxygen Systems from their early days. We helped them develop their patents as well as provided expertise at different stages of their system’s development. We are excited their continued progress in assisting those with autism with their latest paper, “Evolution and Preliminary Testing of a Hyperoxic Therapy for Autism Spectrum Disorders,” (DOI: 10.4172/2165-7890.1000233). This complements their previous paper, “Hypothesis for How Hyperoxic Therapy May Facilitate Effective Biologic “Correction” of Autism Spectrum Disorders“. KES is proud to be able to contribute to this important work and look forward to its continued development.
Recent Posts
- KES supports M4 Engineering and Electra Aero in advancing aerospace technology
- AAFS 2026: Blast, Blast Effects, and Forensic Investigations
- USCG released the Results of the Investigation for the Titan
- Quinton Moore leads LSU research team in materials investigation, presents to panel
- ASME “Career Resource” Webinar – AI in Engineering. Competency, Licensure, and Innovation
- Bart Kemper is a Keynote Speaker for the 2025 ASME VVUQ Conference
- Polyvantis’ main facility, German-engineered transparency
- Visiting the UK’s DEEP facilities


Recent Comments